Sugie Yutaka | Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
スポンサーリンク
概要
- Sugie Yutakaの詳細を見る
- 同名の論文著者
- Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfizeの論文著者
関連著者
-
Imai Aki
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Hirao Akiko
Department Of Biology Graduate School Of Science Osaka University
-
Sugie Yutaka
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Toide Katsuo
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Yamada Yoshinari
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Hayashi Shigeo
Department Of Applied Physecs And Chemistry University Of Electro-communications
-
HAYASHI Shigeo
Department of Applied Physics and Chemistry, University of Electro-Communications
-
Hirao Akiko
Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine
-
SUGIE Yutaka
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
YAMADA Yoshinari
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
TOIDE Katsuo
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
Hirao Akiko
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Hayashi Shigeo
Department Of Discovery Chemistry Research Global Research & Development Nagoya Laboratories Pfi
-
Hayashi Shigeo
Department Of Applied Physics And Chemistry The University Of Electro-communications
-
Hayashi Shigeo
Department of Discovery Chemistry Research, Global Research & Development, Nagoya Laboratories, Pfizer Inc., Japan
-
Sugie Yutaka
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Inc., Japan
著作論文
- Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ-Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent
- Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ–Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent